Therapy Areas: Vaccines
27 September 2023 - YS Biopharma Co., Ltd. (NASDAQ: YS), a China-based global biopharmaceutical company, announced on Tuesday that it has enrolled its first subject in its Phase three clinical trial o...
27 September 2023 - WuXi Vaccines, a China-based contract development and manufacturing organisation (CDMO) focused on vaccine discovery, development, and manufacturing, announced on Tuesday that it h...
25 September 2023 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) announced on Monday that it has signed a new contract valued at a minimum of USD32m with the US Department of Defense ...
19 September 2023 - Clinical-stage biopharmaceutical company Scancell Holdings plc (AIM: SCLP) has shared promising results from the initial stage of its Phase 2 SCOPE trial involving SCIB1 in combina...
19 September 2023 - Biopharmaceutical company Pfizer Inc (NYSE: PFE) announced on Tuesday that it has received European Commission (EC) marketing authorisation for LITFULO (ritlecitinib) to treat seve...
18 September 2023 - YS Biopharma Co Ltd (NASDAQ: YS), a China-based global biopharmaceutical company, announced on Friday that it has received a patent from the United States Patent and Trademark Offi...